Terms: = Pancreatic cancer AND TPM3, ENSG00000143549, 7170
4 results:
1. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with pancreatic cancer.
Zou T; Shi D; Wang W; Chen G; Zhang X; Tian Y; Gong P
Mediators Inflamm; 2023; 2023():5565054. PubMed ID: 37181810
[TBL] [Abstract] [Full Text] [Related]
2. Genetic characteristics and clinical-specific survival prediction in elderly patients with gallbladder cancer: a genetic and population-based study.
Zhou H; Chen J; Jin H; Liu K
Front Endocrinol (Lausanne); 2023; 14():1159235. PubMed ID: 37152947
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and risk factors of cardiovascular mortality in patients with gastrointestinal adenocarcinoma.
Nso N; Nyabera A; Nassar M; Mbome Y; Emmanuel K; Alshamam M; Sumbly V; Guzman L; Shaukat T; Bhangal R; Ojong GA; Radparvar F; Rizzo V; Munira MS
PLoS One; 2023; 18(1):e0262013. PubMed ID: 36706093
[TBL] [Abstract] [Full Text] [Related]
4. Facility type and size-stratified analysis of management patterns and outcomes of patients with localized non-functional pancreatic neuroendocrine tumors.
Hue JJ; Sugumar K; Ammori JB; Rothermel LD; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 Apr; 24(4):498-506. PubMed ID: 34419354
[TBL] [Abstract] [Full Text] [Related]
